Arcus Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 6.3% | 6.3% | 3.3% |
| FY2022 | -40.6% | -40.6% | -19.9% |
| FY2023 | -66.5% | -66.5% | -28.0% |
| FY2024 | -58.4% | -53.1% | -24.6% |
| FY2025 | -55.9% | -48.4% | -31.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 6.3% | 6.3% | 3.3% |
| FY2022 | -40.6% | -40.6% | -19.9% |
| FY2023 | -66.5% | -66.5% | -28.0% |
| FY2024 | -58.4% | -53.1% | -24.6% |
| FY2025 | -55.9% | -48.4% | -31.0% |